-Charles River Laboratories International Inc Dips to Net Loss of Usd334.1m for 2010
M2 EquityBites › February 09, 2011
Linked as:
Summary
EQUITYBITES-(C)2011 M2 COMMUNICATIONS
Drug development company Charles River Laboratories International Inc (NYSE:CRL) reported on Tuesday its net loss (GAAP basis) from continuing operations of USD334.1m (USD5.25 per diluted share) for the full-year 2010.See the full content of this document
Extract
-Charles River Laboratories International Inc Dips to Net Loss of Usd334.1m for 2010
This marks a fall when compa...
See the full content of this document
Sponsored links
